1/2
Images
Prev
Next
Astellas Pharma, New York
Area 23, New York
[3.21.035]
More Info
When your AML patient relapses/progresses – think FLT3 first.
A devastating relapse could transform into a catastrophic disaster if your acute myeloid leukemia (AML) patient has a FLT3 mutation.
- Client Astellas Pharma, New York
- Ad Agency Area 23, New York
- Creative Director Pamela Savage , Tim Hawkey , Vincent Ng
- Art Director Eduardo Tavares , Stephanie Sjaastad , Jeenal Shah
- Copywriter Rhi Burns , Sarah Vallecillo , Ed Serken
- Illustrator Daniel Lievano
More: Area 23 New York
[3.23.123]
1/3
[3.22.097]
1/2
[3.22.096]
1/5
[5.21.067]
1/3
More: Astellas Pharma New York
[BIL.09.100]
1/1
